25.05 : 2012 .
01.01.2012 597,476 . 0,4% 9,5% . , 2012. 27453,4 . (886,45 .), 2% (26822,3 .).
ԙ, 2012. 8% 15,677 . . 2% 7% , 2,008 . (64,979 . .) (.1). (5,33 .) 5,40 . . 12 2012. 141,56 .
2012. (.1). SANOFI-AVENTIS (-3%), SERVIER (-8%) SANDOZ (-4%), 6 7 NOVARTIS (+5%) NYCOMED/TAKEDA (-0,3%). BAYER (-3%) PHARMSTANDART (-11%) 5 . , TEVA (+8%). , GEDEON RICHTER (-9%) PFIZER (-11%). , , 38,3% 37,7%.
(. 2). LASOLVAN (-5%) HEPTRAL (+3%), . LINEX (+5%) OCILLOCOCCINUM (-3%), . ESSENTIALE N (+0,2%), , - ACTOVEGIN (+1%), SUMAMED (+6%) ALFLUTOP (-9%). ARBIDOL 34%, . , 7,9% 7,6%.
XYLOMETAZOLINE (+12%) (.3). PHOSPHOLIPIDS (-1%) 2 . - -10. 3 PANCREATIN (-2%), UMIFENOVIR (-34%) FLUCONAZOLE (-11%), 7 9 . AZITHROMYCIN (+7%) BLOOD (+1%), BIFIDOBACTE-RIUM INFANTIS + ENTEROCOCCUS FAECIUM + LACTOBACILLUS ACIDOPHILUS (+5%) AMOXICILLIN + CLAVULANIC ACID (+1%) 3, 4, 6 8 . PARACETAMOL + ASCORBIC ACID + PHENIRAMINE (+1%). 10,4%.
(.4). J01 (-1%),L03